Selank

Approved (Russia/Ukraine)

Selank (TP-7)

Aliases
TP-7, Selanc
Administration
Intranasal spray, Subcutaneous injection

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Cognitive & Neuroprotection

Selank's defining research application — an anxiolytic peptide studied for calming effects without sedation.

Anxiety reduction

Modulates GABA-A receptor activity to reduce anxiety, similar in target to benzodiazepines but without the sedating effect.

BDNF elevation

Raises levels of a protein essential for the growth and maintenance of neural connections.

Cognitive enhancement

Supports mental clarity as a downstream effect of its calming, non-sedating action on brain chemistry.

Improved focus

Many users report steadier concentration, consistent with its regulation of serotonin and dopamine systems.

Mood stabilization

Regulates serotonin, dopamine, and noradrenaline systems together, rather than targeting a single neurotransmitter.

Neuroprotection

Its cytokine-modulating activity is studied for protecting neurons from stress-related inflammatory damage.

Stress resilience

Inhibits the breakdown of the body's natural enkephalin stress-response compounds, extending their calming effect.